Synthesis and Processing of the Equine Herpesvirus 1 Glycoprotein M  by Osterrieder, Nikolaus et al.
VIROLOGY 232, 230–239 (1997)
ARTICLE NO. VY978561
Synthesis and Processing of the Equine Herpesvirus 1 Glycoprotein M
Nikolaus Osterrieder,*,1 Antonie Neubauer,* Bernd Fakler,† Christine Brandmu¨ller,* Christian Seyboldt,*
Oskar-Ru¨ger Kaaden,* and Joel D. Baines‡
*Institute for Medical Microbiology, Infectious and Epidemic Diseases, Ludwig-Maximilians-University Mu¨nchen, Veterina¨rstraße 13, 80539
Munich, Germany; †Section for Sensoric Biophysics, Eberhard-Karls-University Tu¨bingen, Ro¨ntgenweg 11, 72076 Tu¨bingen, Germany; and
‡Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853-6401
Received February 25, 1997; returned to author for revision March 10, 1997; accepted March 27, 1997
In a previous report, the function of the equine herpesvirus 1 (EHV-1) glycoprotein M (gM) homolog was investigated. It
was shown that EHV-1 gM is involved in both virus entry and direct cell-to-cell spread of infection (N. Osterrieder et al., J.
Virol. 70, 4110–4115, 1996). In this study, experiments were conducted to analyze the synthesis, posttranslational processing,
and the putative ion channel function of EHV-1 gM. It was demonstrated that EHV-1 gM is synthesized as an Mr 44,000
polypeptide, which is cotranslationally N-glycosylated to an Mr 46,000–48,000 glycoprotein. The Mr 46,000–48,000 gM
moiety is processed to an Mr 50,000–55,000 glycoprotein, which is resistant to treatment with endoglycosidase H, indicating
that processing occurs in the Golgi network. EHV-1 gM forms a dimer in infected cells and the virion, as was demonstrated
by the presence of an Mr 105,000–110,000 gM-containing band in electrophoretically separated lysates of infected cells
and purified extracellular virions. The Mr 105,000–110,000 protein band containing gM was also observed in lysates of
cells that had been transfected with EHV-1 gM DNA. The translation of EHV-1 gM is initiated at the first in-frame methionine
of the gM open reading frame as shown by transient transfection experiments of full-length gM and a truncated gM lacking
the aminoterminal 83 amino acids. Functional expression of EHV-1 gM in Xenopus laevis oocytes together with voltage-
clamp analyses demonstrated that gM per se does not exhibit ion channel activity as had been speculated from the predicted
structure of the polypeptide. q 1997 Academic Press
INTRODUCTION (Whittaker et al., 1991). The other glycoprotein, referred
to as gp1/2 or gp300, is a highly O-glycosylated envelope
Equine herpesvirus 1 (EHV-1), a member of the alpha-
protein, which has recently been shown to be encoded
herpesvirinae, causes respiratory disease, abortion, and
by gene 71 (Sun et al., 1996; Wellington et al., 1996).
neurological disease in horses (O’Callaghan et al., 1983;
Most EHV-1 glycoproteins represent type I transmem-Allen and Bryans, 1986; Mumford et al., 1995). The se-
brane proteins and studies on the synthesis, processing,quence of the EHV-1 genome predicts that EHV-1 en-
and function of EHV-1 gB, gD, gH, gL, and the genecodes for at least 76 polypeptides. To date, 10 of the open
71 product have been performed (Meredith et al., 1989;reading frames have been shown to encode proteins that
Sullivan et al., 1989; Whalley et al., 1989; Flowers et al.,exhibit typical features of glycoproteins and their amino
1995; Stokes et al., 1996; Sun et al., 1996; Neubauer etacid sequences indicate that they are homologous to
al., 1997).proteins found in other herpesviruses, like herpes sim-
The EHV-1 gM homologous protein is encoded byplex virus 1 (HSV-1), the prototype of the alphaherpesviri-
gene 52- of the 150-kbp EHV-1 genome (Telford et al.,nae (Telford et al., 1992). Following the current nomencla-
1992; Pilling et al., 1994), and was shown to be involvedture, these EHV-1 glycoproteins are named according
in virus penetration and direct cell-to-cell spread (Ost-to their counterparts in HSV-1 and are referred to as
errieder et al., 1996). The homologs of HSV-1 gM areglycoproteins B, C, D, E, G, H, I, K, L, and M (gB, gC, gD,
unusual for two reasons. First, gM is unique amonggE, gG, gH, gI, gK, gL, and gM, respectively) (Telford et
herpesvirus glycoproteins because it is conserved inal., 1992). In addition to the glycoproteins described
all herpesviral subfamilies but is not essential for virusabove, at least two other EHV-1 glycoproteins have been
growth in cultured cells (Lehner et al., 1989; Albrechtidentified. One of these glycoproteins, gp10, is homolo-
et al., 1992; Baines and Roizman, 1993; MacLean etgous to VP13/14 of HSV-1 and is not present in the viral
al., 1993; Dijkstra et al., 1996; Osterrieder et al., 1996).envelope but represents a component of the tegument
Second, gM and gK are the only type III transmem-
brane glycoproteins encoded by the alphaherpesviri-1 To whom correspondence and reprint requests should be ad-
nae, and gM is predicted to contain six to eight mem-dressed. Fax: /49-89-2180-2597. E-mail: klaus.osterrieder@lrz.uni-
muenchen.de. brane-spanning regions (McGeoch et al., 1988; Telford
2300042-6822/97 $25.00
Copyright q 1997 by Academic Press
All rights of reproduction in any form reserved.
AID VY 8561 / 6a36$$$201 04-29-97 15:53:36 viras AP: Virology
231SYNTHESIS OF EHV-1 gM
et al., 1992; Zhao et al., 1992; Dijkstra et al., 1996). Expression of gM in COS7 cells
Whereas the gM molecules identified to date do not
Twenty micrograms of pCgM or pCgM83 plasmid DNAshare extensive primary amino acid sequence homol-
were transfected into 1 1 106 COS7 cells by electropora-ogy, the number of transmembrane domains, and over-
tion (GenePulser, Bio-Rad). At different times after elec-all hydrophobicity among gM homologs are highly con-
troporation, cell lysates were prepared for immunoblotserved. This suggests that gM homologs may function
analysis using mab 13B2 (see below).analogously, although not necessarily identically, in
different herpesvirus systems. Further analyses of the Protein analyses
secondary structure of the gM homologs led to the
speculation that gM might form an ion channel or func- Rk13 or Edmin337 cells were infected at a multiplicity
of infection (m.o.i.) of 3. At different times after infection,tion as a ligand for low molecular weight molecules
(Baines and Roizman, 1993; Pilling et al., 1994). Consis- cell lysates were prepared (Sambrook et al., 1989). The
protein content of the lysates was determined (BCA pro-tent with its hydrophobic nature, gM was found to ag-
gregate into large complexes upon heating in the pres- tein assay, Pierce) and was adjusted to 5 mg protein/ml.
Identical amounts of protein were suspended in sampleence of sodium dodecyl sulfate (Baines and Roizman,
1993; Pilling et al., 1994; Dijkstra et al., 1996; Oster- buffer (final concentration: 50 mM Tris–Cl, pH 6.8; 3.2%
sodium dodecyl sulfate (SDS); 10% glycerol) with or with-rieder et al., 1996).
The aims of this study were to extend the characteriza- out the addition of 5% 2-mercaptoethanol (2-ME), and
samples were heated at either 567 for 2 min, at 957 fortion of EHV-1 gM and to analyze its synthesis, pro-
cessing, and putative ion channel function. 5 min, or were placed on ice immediately. Proteins were
then separated by discontinuous SDS-10%-polyacryl-
amide gel electrophoresis (PAGE) (Laemmli, 1970) and
MATERIALS AND METHODS
were transferred to nitrocellulose membranes by the
semi-dry method (Kyhse-Andersen, 1984). The nitrocellu-Virus and cells
lose sheets were blocked with skim milk powder [10%
in phosphate-buffered saline containing 0.05% Tween 20The EHV-1 strain analyzed in this study was RacL11
which was propagated on the equine dermal cell line (PBS-T)] and were incubated with anti-EHV-1 gM mono-
clonal antibody (mab) 13B2 (1:5,000 in PBS-T) (Allen andEdmin337 maintained in Eagle’s modified DMEM supple-
mented with 10% fetal calf serum (FCS) (Hu¨bert et al., Yeargan, 1987; kindly provided by Dr. G.P. Allen, Lexing-
ton, KY) or a monospecific anti-gM mouse antiserum1996; Osterrieder et al., 1996). Rk13 cells, the cell line
TCgM constitutively expressing EHV-1 gM (Osterrieder (1:100 in PBS-T) produced after intramuscular injection
of pCgM plasmid DNA in mice (Osterrieder et al., 1996).et al., 1996), and COS7 cells were grown in the same
medium. Bound antibodies were detected with an anti-mouse IgG
antibody conjugated with alkaline phosphatase (Sigma)
followed by precipitation of colored substrate using ni-Plasmids
troblue tetrazolium and 5-bromo-4-chloro-3-indolyl phos-
phate according to the supplier’s instructions (Boeh-The recombinant plasmid pCgM containing EHV-1
gM under the control of the human cytomegalovirus ringer).
For immunoprecipitations, 1 1 106 Rk13 cells were in-immediate early promoter has been previously de-
scribed (Osterrieder et al., 1996). The plasmid pCgM83, fected with RacL11 at an m.o.i. of 5. At 8.5 hr after infec-
tion, amino acid pools were depleted for 25 min using alacking the aminoterminal 83 amino acids of the pre-
dicted gM open reading frame, was generated by methionine- and cysteine-free DMEM (ICN), and cells
were then pulse-labeled with 200 mCi/ml [35S]methioninecleaving pCgM with the restriction enzymes BamHI
and Sau3AI. The protruding 5*-overhangs were blunted and -cysteine (Tran-35S-label, ICN) for 20 min. The label-
ing medium was replaced with medium containing a 10-with the Klenow fragment of Escherichia coli DNA poly-
merase I (Sambrook et al., 1989) and were religated. fold excess of unlabeled methionine. At different times
after the labeling period, cell lysates were prepared. TwoFull-length EHV-1 gM was subcloned into pBF1, a
pSP64T-derived vector designed for functional expres- microliters of 13B2 ascites fluid was added to the radiola-
beled lysates and antigen–antibody complexes weresion of genes in Xenopus laevis oocytes (Fakler et al.,
1995). EHV-1 gM in pBF1 is referred to as pXLgM. purifed as previously described (Neubauer et al., 1997).
In some experiments, Rk13 cells were infected withCapped EHV-1 gM-specific RNA was transcribed from
pXLgM in vitro using SP6 polymerase and stored in RacL11 (m.o.i.  5) for 24 hr and infected cells were
pelleted and directly resuspended in deglycosylationstocks at 0707 until use. A schematic diagram de-
picting the sequences of these plasmids is shown in buffers. For treatment with PNGase F (Boehringer), 1 1
106 cells were resuspended in 500 ml of a phosphateFig. 1.
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FIG. 1. Schematic illustration of the generated plasmids. The BamHI-restriction map of EHV-1 strain RacL11 and the location of the gM-gene
(gene 52) are shown. Inverted repeat sequences are shown as shaded rectangles. The plasmid pCgM was generated after PCR amplification of
the RacL11 gM gene and cloning into the eucaryotic expression vector pcDNAI/Amp (Osterrieder et al., 1996). The plasmids pCgM83 and pXLgM
were derived from pCgM by subcloning as outlined under Material and Methods. Restriction enzyme sites are abbreviated: E, EcoRI; P, PstI; S,
Sau3A1. The start codons of pCgM and pCgM83 are indicated (ATG), and the b-globin flanking regions in pXLgM are shown as white rectangles.
buffer (pH 7.0), which contained 0.5% NP-40, 100 mg/ml microelectrode voltage-clamp or giant patch-clamp re-
cording. Current and voltage electrodes were pulled frombovine serum albumin (BSA), and a cocktail of proteinase
inhibitors (1 mM PMSF, 1 mg/ml final concentration of thick-walled borosilicate glass, had resistances of 0.1 to
0.5 V, and were filled with 3 M KCl. Currents were re-aprotinin, leupeptin, TLCK, and TPCK; all proteinase in-
hibitors from Sigma). Identical aliquots (100 ml) were in- corded with a TurboTec 01C amplifier (npi, Tamm, FRG),
digitized at 0.1 kHz (ITC16, HEKA, Lamprecht, FRG), andcubated in the absence or presence of 100 mU PNGaseF
(Boehringer) for 16 hr at 377 before the reaction was the data were stored on harddisk. The bath chamber was
made up as a narrow canal to achieve complete solutionterminated by the addition of sample buffer containing
5% 2-ME. For treatment with EndoH (Boehringer), 1 1 exchanges in less than 10 sec. The normal frog Ringer
(NFR) solution was composed as follows (in mM): 115.5106 cells were resuspended in 500 ml of 2.5 M sodium
acetate (pH 5.5) containing 0.5% NP-40, 100 mg/ml BSA, NaCl, 2.5 KCl, 1.8 CaCl2 , 10 HEPES, or 27.5 NaCl, 90 KCl,
1.8 CaCl2 , 10 HEPES, and the pH was adjusted to 7.2.and proteinase inhibitors. Identical 100-ml samples were
incubated in the presence (2 mU) or absence of the en-
zyme for 16 hr at 377. After separation of the proteins by RESULTS
SDS-10%-PAGE and transfer to nitrocellulose, EHV-1 gM
Kinetics of EHV-1 gM synthesiswas detected using mab 13B2.
To analyze the kinetics of EHV-1 gM synthesis in in-
Preparation and injection of Xenopus laevis oocytes
fected cells, lysates of RacL11-infected cells were pre-
and electrophysiology
pared at 2, 4, 6, 8, 10, 12, 16, and 24 hr post infection
(p.i.). The lysates (50 mg of total protein) were separatedXenopus laevis oocytes were removed surgically from
adult females and dissected manually. For expression of on individual lanes of an SDS-10%-polyacrylamide gel
and analyzed by immunoblotting using the gM-specificEHV-1 gM in Xenopus laevis oocytes, gM-specific RNA
was transcribed from plasmid pXLgM and approximately mab 13B2 as described under Materials and Methods.
The results, shown in Fig. 2, indicated that an apparent50 ml of a solution containing 10 ng of EHV-1 gM-specific
RNA was injected into Dumont stage VI oocytes. Oocytes Mr 46,000–48,000 protein was detected by mab 13B2
starting at 4 hr p.i. From 6 hr p.i., a second protein specieswere treated with collagenase type II (Sigma, 0.5 mg/ml)
and incubated at 197 for 1 –3 days before use (Fakler et of apparent Mr 50,000–55,000 reacted with the antibody.
As visualized on the immunoblot, the relative amounts ofal., 1995). Some oocytes were used for patch-clamp or
voltage-clamp analysis, and 10 oocytes were processed the detected gM protein species changed during the
course of infection such that the Mr 50,000–55,000 spe-for analysis on immunoblots probed with a gM-specific
antiserum (Osterrieder et al., 1996). cies became more prominent with time. Thus, at 6 hr p.i.
approximately 90% of the gM-specific reactivity wasElectrophysiological recordings were performed 3 to
7 days after injection of gM-specific RNA using a two- found in the lower Mr band, whereas at 12 and 16 hr p.i.,
AID VY 8561 / 6a36$$$201 04-29-97 15:53:36 viras AP: Virology
233SYNTHESIS OF EHV-1 gM
both the Mr 46,000–48,000 and 50,000–55,000 proteins
reacted with nearly equal intensity.
Pulse–chase analysis of EHV-1 gM
The above experiments suggested that the Mr 46,000 –
48,000 gM species can undergo processing to give
rise to the Mr 50,000–55,000 protein. To test this possibil-
ity, pulse–chase analyses were performed. Rk13 cells
were infected with RacL11 (m.o.i.  5) for 8.5 hr, and
viral proteins were labeled with [35S]methionine and
-cysteine for 20 min. Immediately after the pulse (time
0), and after 15, 30, 45, 60, 90, and 240 min of chase in
the presence of a 10-fold excess of unlabeled methio-
nine, cell lysates were prepared and analyzed by immu-
noprecipitation using mab 13B2. Identical aliquots of the
immunoprecipitates were suspended in sample buffer in
the presence or absence of 5% 2-ME and were analyzed
by SDS-10%-PAGE followed by autoradiography. After FIG. 3. Pulse–chase analysis of EHV-1 gM. RacL11-infected cells
heating the samples for 2 min at 567 in the presence of were pulse-labeled at 8.5 hr p.i. with [35S]methionine and -cysteine for
20 min. At various times of chase (0, 15, 30, 60 min) with an excess2-ME, the Mr 46,000–48,000 gM protein was detected
of unlabeled methionine, cell lysates were prepared and subjected toimmediately after the pulse (time 0; Fig. 3). After a 15-
immunoprecipitation using mab 13B2. Identical aliquots of the immuno-min chase period, both the Mr 46,000–48,000 gM moiety precipitates were suspended in the presence (/2-ME) or absence
and a very faint reaction of the Mr 50,000–55,000 gM (02-ME) of 2-mercaptoethanol and subjected to SDS-10%-PAGE. After
band, that was visible on the original autoradioagram, separation, the gel was fixed, dried, and subjected to autoradiography.
Molecular weights of a prestained molecular weight standard (Gibco-were detected. Thus, both gM bands were precipitated
BRL) are indicated in thousands. Coimmunoprecipitated proteins (Mrspecifically from infected cell lysates from 15 to 240 min
90,000 and 140,000) are indicated by arrowheads.after the pulse (Fig. 3; data shown for 0, 15, 30, and 60
min). Because only the Mr 46,000–48,000 was radiola-
beled immediately after the pulse, whereas radioactivity
was later chased into the Mr 50,000–55,000 protein, we
conclude that EHV-1 gM is produced as an apparent Mr
46,000–48,000 protein moiety which is further processed
to an Mr 50,000–55,000 species.
It was also noted that, starting at 30 min after the
pulse, additional faint bands of apparent Mr 90,000 and
140,000 could be detected in the immunoprecipitates un-
der reducing conditions. Although the exact origin of the
proteins in these bands is unknown, we view it as un-
likely that such species contain gM because, unlike gM,
the protein in these bands does not aggregate into insep-
arable species when heated to 957 (data not shown). The
data therefore suggests that these minor bands do not
contain gM but represent viral or cellular proteins that
coimmunoprecipitate with gM.
Previous studies suggested that additional gM con-
taining species were accentuated under nonreducing
conditions. To characterize such species, the immuno-
FIG. 2. Immunoblot analysis of RacL11-infected cell lysates at differ- precipitates described above were electrophoretically
ent times after infection. Cell lysates were harvested at the indicated separated in the absence of the reducing agent 2-ME.
time points p.i. and adjusted to equal protein concentrations. After Under such conditions, bands of apparent Mr 46,000–heating the samples at 567 for 2 min, proteins were separated by SDS-
48,000, 55,000–57,000, and 59,000–61,000 were ob-10%-PAGE, transferred to nitrocellulose and incubated with mab 13B2.
served in samples chased from 0 to 240 min after theMolecular weights of a prestained molecular weight standard (Gibco-
BRL) are indicated in thousands. pulse labeling period. Because the 55,000–57,000 and
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59,000–61,000 gM moieties were not detectable under cells infected with RacL11 were incubated for 24 hr in
the absence or presence of 1 (or 5) mg/ml tunicamycin,reducing conditions, the bands likely arise as a conse-
quence of intramolecular disulfide bond formation (Fig. and immunoblots of the infected-cell lysates were probed
with the gM-specific mab 13B2. As little as 1 mg tuni-3). In addition, a prominent band of Mr 105,000–110,000
was also detected in the absence of the reducing agent camycin per milliliter of cell culture medium led to the
disappearance of the Mr 46,000–48,000 and 50,000–2-ME (Fig. 3). Because this band, like other gM species,
was absent in lanes containing samples heated at 957 55,000 protein bands. Instead, an apparent Mr 44,000
protein was detected with the gM-specific antibody (Fig.and was immunoprecipitated with the gM-specific mab
13B2, we conclude that the 105,000–110,000 apparent 4B, arrowhead). From these results it was concluded that
EHV-1 gM has a polypeptide backbone of apparent MrMr band contains gM. Thus, this data strongly suggests
that EHV-1 gM molecules form disulfide bonds with other 44,000 that is cotranslationally modified by addition of
N-linked sugars to an Mr 46,000–48,000 glycoprotein. Byproteins. The observations that the Mr 105,000–110,000
protein is approximately twice the molecular weight of passage through at least the medial Golgi compartment
(as demonstrated by the resistance of the sugars in thisother gM species and that the interacting proteins pres-
ent in the Mr 105,000–110,000 complex are not resolved protein to digestion with EndoH), the gM protein is further
modified to an Mr 50,000–55,000 protein.if heated at 957 (see below) indicate that gM may form
a disulfide-linked homodimer.
EHV-1 gM translation starts at the first in-frame
methionineEHV-1 gM is N-glycosylated
Two approaches were taken to address the nature of The predicted molecular weight of EHV-1 gM as de-
duced from the amino acid sequence is 49,218 (Telfordthe co- and posttranslational processing of EHV-1 gM.
(i) Rk13 cells were infected with RacL11 at an m.o.i. of et al., 1992). In previous reports, the apparent molecu-
lar weight of EHV-1 gM as determined after SDS –5 for 24 hr and cell lysates were prepared and suspended
in the appropriate buffers for treatment with PNGaseF, PAGE ranged from Mr 43,000 to 55,000 (Allen and Year-
gan, 1987; Pilling et al., 1994; Osterrieder et al., 1996).EndoH, or O-glycosidase. Whereas PNGaseF cleaves all
N-linked sugar moieties, EndoH is able to cleave only These differences in the reported apparent Mr of
EHV-1 gM led us to experimentally address whethersimple high-mannose N-linked sugars. The lysates were
incubated in the presence or absence of the various translation of EHV-1 gM is initiated at the first in-frame
methionine. Plasmid DNA containing either full-lengthglycosidases for 16 hr at 377 and separated by SDS-10%-
PAGE. The cell lysates were then transferred to nitrocel- EHV-1 gM (pCgM), or an aminoterminally truncated
version of the ORF (pCgM83), which (i) lacks the firstlulose and analyzed by immunoblotting using mab 13B2.
The results of these experiments are shown in Fig. 4A. 83 amino acids of gM, (ii) is devoid of the predicted
N-glycosylation site, and (iii) starts with the second in-Neither the Mr 46,000–48,000 nor the 50,000–55,000 gM
moiety was affected by treatment with O-glycosidase frame methionine of gene 52 (Telford et al., 1992), were
separately transfected into COS7 cells. The expressed(data not shown). In contrast, infected-cell lysates treated
with PNGaseF contained an apparent Mr 44,000 protein proteins were analyzed by SDS-10%-PAGE followed by
immunoblot analysis using mab 13B2. The results arethat specifically reacted with the 13B2 antibody. Incuba-
tion of the infected-cell lysate with PNGaseF deglycosyl- shown in Fig. 5. The cell lysate prepared after transfec-
tion of full-length EHV-1 gM contained the Mr 46,000 –ation buffer in the absence of the enzyme had no influ-
ence on either the Mr 46,000–48,000 or 50,000–55,000 48,000 gM moiety, the primarily glycosylated form of
gM that was also observed in infected cells, and the MrgM moieties. Treatment of the infected-cell lysate with
EndoH left the larger gM moiety of Mr 50,000–55,000 105,000 – 110,000 gM-containing protein. In contrast, a
band with an apparent Mr of 40,000 was detected byunaffected; however, the Mr 46,000–48,000 gM band was
reduced in size to an Mr 44,000 band (Fig. 4A). Incubation the gM-specific antibody in pCgM83-transfected cell
lysates. In addition, an Mr 27,000 protein was specifi-of the cell lysate in EndoH buffer alone had no detectable
effect on the Mr 46,000–48,000 gM species. The appear- cally detected by the 13B2 antibody (Fig. 5). The ob-
served apparent Mr of 40,000 in pCgM83-transfectedance of a broad band containing gM in the stacking gel
after incubation with the deglycosylation buffers in the cells exactly corresponds to the calculated molecular
mass of the engineered EHV-1 gM protein that startsabsence or presence of enzymes at 377 for 16 hr may
result from an aggregation of the highly hydrophobic gM at the second in-frame methionine of gene 52. The
smaller band reacting in pCgM83-transfected cell ly-as has been demonstrated earlier for EHV-1 gM that is
heated at 957 (Pilling et al., 1994; Osterrieder et al., 1996). sates might originate from degradation of the Mr 40,000
protein or might represent a translation product start-(ii) To confirm the hypothesis that glycosylation of gM
was due to the addition of N-linked polysaccharides, ing from the third in-frame methionine at codon 197 of
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FIG. 4. (A) Immunoblot analysis of RacL11-infected cell lysates treated with endoglycosidases. Cell lysates were prepared at 24 hr p.i. and
suspended in buffers suitable for PNGaseF or EndoH digestion and incubated in the absence (0) or presence (/) of the respective enzyme
for 16 hr at 377. Untreated infected cell lysates (RacL11) and mock-infected cell lysates (mock) are indicated. Samples were suspended in
sample buffer, heated at 567 for 2 min, and separated by SDS-10%-PAGE. After transfer to nitrocellulose, gM was detected using mab 13B2.
Molecular weights of a prestained molecular weight standard (Gibco-BRL) are indicated in thousands. (B) Immunoblot analysis of tunicamycin-
treated infected cell lysates prepared at 24 hr after infection. Cell lysates were prepared, separated by SDS-10%-PAGE, and transferred to
nitrocellulose. EHV-1 gM was detected as described in A. The tunicamycin concentrations that were added throughout the incubation period
are indicated in mg/ml cell culture medium (0, 1, and 5 Tun). The Mr 44,000 gM-containing band present after addition of tunicamycin is
indicated by an arrowhead.
the 450 amino acid polypeptide. Consistent with the without 2-ME were left on ice. Lysates of extracellular
latter interpretation is that the calculated Mr of the EHV-1 virions that had been purified by sucrose gradi-
polypeptide initiated from the methionine-197 is 27,992 ent centrifugation (Osterrieder et al., 1996) were
(Devereux et al., 1984). It should be noted that in treated accordingly and were analyzed by SDS-10%-
pCgM83-transfected cells no higher molecular weight PAGE and immunoblotting using a monospecific anti-
protein corresponding to a gM dimer was observed gM mouse antiserum (Osterrieder et al., 1996). The
(Fig. 5). In control cell preparations that were trans- results indicated that whereas in infected cell lysates
fected with the vector pcDNAI/Amp alone, no reactivity the Mr 46,000 – 48,000 and the Mr 50,000 – 55,000 gM
with mab 13B2 could be demonstrated (Fig. 5). Taken moieties were detectable, lysates of virions heated at
together, these results clearly indicated that (i) transla- 567 in the presence of 2-ME contained Mr 50,000 –
tion of EHV-1 gM is initiated at the first in-frame methio- 55,000 and 110,000 – 115,000 proteins (Fig. 6). Heating
nine as demonstrated by increased electrophoretic the samples at 957 led to the aggregation of all gM
mobilities of EHV-1 gM upon transfection of pCgM83, species in infected-cell lysates and purified virions. As
(ii) shortened gM molecules lacked co- and posttrans- a consequence, gM reactivity was isolated to a broad
lational modification by N-glycosylation (data not band in the stacking gel (Fig. 6). In infected cell lysates
shown), and (iii) shortened gM molecules lacked the separated without the addition of 2-ME, a prominent
ability to form higher molecular weight species that protein band of apparent Mr 105,000 – 110,000 was de-
might represent gM homodimers. tected, consistent with the formation of a disulfide-
linked gM dimer (see Fig. 3). In purified virions, the
Analysis of EHV-1 gM in infected cells and purified same Mr 110,000 – 115,000 as was detected in the pres-virions ence of 2-ME and higher Mr proteins containing gM
were detected (Fig. 6). Thus, EHV-1 gM is present inTo compare the nature of the gM proteins present
different forms in infected cells and purified virions.in infected cells and in purified EHV-1 virions, lysates
Whereas the 105,000 – 110,000 species in infectedof RacL11-infected Rk13 cells were prepared at 16 hr
cells was cleavable by 2-ME, the Mr 110,000 – 115,000p.i. and were suspended in sample buffer with or with-
gM moiety in purified virions was not completelyout the addition of 2-ME. Samples containing 2-ME
were heated to either 567 or 957, whereas samples cleaved in the presence of 2-ME. It is further concluded
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that only the EndoH-resistant gM moiety (Mr 50,000 –
55,000) is incorporated into purified virions. Thus, as
observed for other herpesviral and EHV-1 glycopro-
teins, only fully processed forms of EHV-1 gM are pres-
ent in extracellular virions (Sullivan et al., 1989; Spear,
1993; Flowers et al., 1995).
EHV-1 gM does not reconstitute an ion channel
To document EHV-1 gM ion channel function, Xenopus
laevis oocytes were microinjected with 10 ng of EHV-1
gM-specific RNA flanked by the 5* and 3* untranslated
regions of the Xenopus laevis b-globin gene to enhance
protein expression (Fakler et al., 1995). At different times
after transfection, voltage-clamp analyses were per-
formed. As shown in Fig. 7, no differences in the currents
could be detected between oocytes injected with EHV-1
gM-specific RNA and those injected with water under
different conditions. Since expression of EHV-1 gM in
cRNA-injected oocytes could be confirmed by Western
blot analysis (data not shown), this data indicates that
EHV-1 gM per se does not reconstitute an ion channel.
FIG. 6. Immunoblot analysis of EHV-1 gM in infected cells and puri-
fied virions. Lysates of infected cells (16 hr p.i.) and purified virions
were incubated in the presence of 2-ME and heated at 567 for 2 min
(/2-ME, 567) or at 957 for 5 min (/2-ME, 957). Identical aliquots were
suspended in buffer containing no 2-ME (02-ME). The lysates were
separated by SDS-10%-PAGE, transferred to nitrocellulose, and de-
tected using a gM-specific antiserum (Osterrieder et al., 1996). Molecu-
lar weights of a prestained molecular weight standard (Gibco-BRL) are
indicated in thousands. The origin of the separating gel is indicated
by an arrowhead.
DISCUSSION
In this study analyses on the synthesis and processing
of the EHV-1 glycoprotein M and its putative ion channel
function were performed. These analyses add to and
extend the functional characterization of the major enve-
lope constituent of EHV-1 virions which is involved in
virus penetration and direct cell-to-cell spread of infec-
tion (Allen and Yeargan, 1987; Osterrieder et al., 1996).
Western blot and pulse–chase experiments demon-
strated that EHV-1 gM is detectable in infected cells from
4 hr p.i. as a cotranslationally N-glycosylated Mr 46,000–
48,000 protein, which is further modified to yield an Mr
50,000–55,000 molecule. The gM moieties represent par-
tially and fully processed glycoproteins, respectively,
FIG. 5. Immunoblot analysis of COS7 cells transfected with pCgM
which are derived from an Mr 44,000 primary translationor pCgM83. Twenty-micrograms of the respective plasmids were trans-
product. Only the fully processed Mr 50,000–55,000 gMfected into 1 1 106 COS7 cells. Cell lysates were prepared at 72 hr
after transfection, suspended in sample buffer without 2-ME. Cell ly- protein is detectable in extracellular virions. Additionally,
sates were separated by SDS-10%-PAGE, transferred to nitrocellulose, gM is present in virions as an Mr 110,000–115,000 pro-
and incubated with mab 13B2. Molecular weights of a prestained mo- tein species that might represent a homodimer which
lecular weight standard (Gibco-BRL) are indicated in thousands. The
was partially resistant to treatment with reducing agents.gM dimer in pCgM-transfected cells is marked by an arrow. The Mr
In contrast, the putative gM homodimer (Mr 105,000–40,000 and 27,000 proteins in pCgM83-transfected cells are indicated
by arrowheads. 110,000) in infected cells and also in cells transiently or
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FIG. 7. (A) Currents recorded in reponse to voltage jumps of 2-sec duration going from 0120 to 40 mV in 10 mV increments. Oocytes were
injected with either water or 10 ng of EHV-1 gM-specific RNA that was transcribed from recombinant plasmid pXLgM. (B) Current – voltage
relation measured in water-injected oocytes and in oocytes injected with EHV-1 gM-specific RNA. Current was recorded in response to voltage-
ramps going from 0100 to 100 mV in 5 sec. External potassium concentrations (90 and 2.5 mM K/) are indicated.
constitutively expressing gM (Osterrieder et al., 1996) in cells transfected with DNA encoding full-length gM
was consistent with earlier observations and indicatedwas fully susceptible to 2-ME.
Immunoprecipitation analyses demonstrated the co- that the maturation of gM is incomplete in transfected
cells and is dependent on the time point of cell lysateprecipitation of gM with proteins of apparent Mr of 90,000
and 140,000, which are detectable only under denaturing preparation after transfection (Osterrieder et al., 1996).
The incomplete maturation of gM in the absence ofconditions. At present, these proteins cannot be identi-
fied as either viral or cellular components, especially other viral proteins might suggest that correct pro-
cessing of gM requires other EHV-1 gene product(s).since EHV-1 is severely impaired in virus host shutoff
activity compared with HSV-1 (Feng et al., 1996). The Due to the deletion of the glycosylation consensus site
(Asn – His – Ser; residues 75 – 77), no glycosylation ofdata, however, might suggest an interaction of gM with
other viral protein(s) and this possibility is currently under the truncated polypeptides encoded by pCgM83 was
observed. From these results it was concluded thatinvestigation.
By transfecting full-length or an aminoterminally translation of EHV-1 gM initiates at the first in-frame
methionine, that gM is cotranslationally glycosylatedtruncated version (lacking aa 1 to 83) of EHV-1 gM
into COS7 cells and subsequent Western blot analysis, at the predicted N-glycosylation consensus site and
that it is finally processed to the mature protein. Stillconclusive evidence is presented that translation of
EHV-1 gM is initiated at the first in-frame methionine unresolved is the presence of a cleavable N-terminal
signal peptide in EHV-1 gM. As predicted by the rulesas predicted by Telford et al. (1992). It was shown that
the Mr 46,000 – 48,000 primary glycosylation product of of von Heijne (1986), two potential signal peptide cleav-
age sites are present in the molecule. The first cleav-gM was only detected in cells transfected with full-
length EHV-1 gM DNA, but not in cells transfected with age site between residues 46 (Ser) and 47 (Val) would
result in a polypeptide of a predicted molecular masspCgM83 that lacks the first in-frame methionine of
gene 52. By transfecting pCgM83 DNA, gM-derived of 44,423 and the second between residues 57 (Pro)
and 58 (Gln) in an Mr 43,267 polypeptide (Devereux etproteins with enhanced electrophoretic mobilities (Mr
40,000 and 27,000) were produced. The absence of the al., 1984). At present, we cannot exclude cleavage at
either site. However, the apparent Mr of the unglycosyl-fully glycosylated form of EHV-1 gM (Mr 50,000 – 55,000)
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Flowers, C. C., Flowers, S. P., Jennings, S. R., and O’Callaghan, D. J.ated form of gM (44,000) is much smaller than the
(1995). Synthesis and processing of equine herpesvirus 1 glycopro-predicted Mr of 49,213 of uncleaved gM, suggesting tein D. Virology 208, 9–18.
that EHV-1 gM is cotranslationally cleaved at an N- Hu¨bert, P. H., Birkenmaier, S., Rziha, H. J., and Osterrieder, N. (1996).
terminal signal peptide. The characteristics of a cleav- Alterations in the equine herpesvirus type-1 (EHV-1) strain RacH
during attenuation. J. Vet. Med. B 43, 1–14.able signal peptide, a total of eight possible transmem-
Kyhse-Andersen, J. (1984). Electroblotting of multiple gels: A simplebrane domains (Telford et al., 1992), and the fact that
apparatus without buffer tank for rapid transfer of proteins from poly-the long carboxyterminal hydrophilic domain is located
acrylamide to nitrocellulose. J. Biochem. Biophys. Methods 10, 203–
at the cytoplasmic side of the plasma membrane (Ost- 214.
errieder et al., 1996) strongly suggest that the mature Laemmli, U. K. (1970). Cleavage of structural proteins during the assem-
bly of the head of bacteriophage T4. Nature (London) 227, 680–685.gM protein contains an odd number of transmembrane
Lehner, R., Meyer, H., and Mach, M. (1989). Identification and character-domains. Additionally, EHV-1 gM might be present as
ization of a human cytomegalovirus gene coding for a membranea homodimer in both infected cells and the virion. By
protein that is conserved among human herpesviruses. J. Virol. 63,
generating anti-peptide antisera directed against the 3792–3800.
hydrophilic domains of the molecule, the verification of MacLean, C. A., Robertson, L. M., and Jamieson, F. E. (1993). Character-
ization of the UL10 gene product of herpes simplex virus type 1 andthe gM topology in membranes is under investigation.
investigation of its role in vivo. J. Gen. Virol. 75, 975–983.In the last set of experiments, the putative ion channel
McGeoch, D. J., Dalrymple, M. A., Davison, A. J., Dolan, A., Frame, M. C.,function of EHV-1 gM was assessed. As deduced from
McNab, D., Perry, L. J., Scott, J. E., and Taylor, P. (1988). The complete
the results of the patch-clamp and voltage-clamp experi- DNA sequence of the long unique region in the genome of herpes
ments after transfection of gM RNA into Xenopus laevis simplex virus type 1. J. Gen. Virol. 69, 1531–1574.
Meredith, D. M., Stocks, J.-M., Whittaker, G. R., Halliburton, I. W., Snow-oocytes, gM per se does not exhibit the features of an
den, W. B., and Killington, R. A. (1989). Identification of the gB homo-ion channel. However, since gM appears to be closely
logues of equine herpesvirus types 1 and 4 as disulphide-linkedassociated with other viral or cellular proteins, a coopera-
heterodimers and their characterization using monoclonal antibod-
tion of other protein(s) with gM in such a function cannot ies. J. Gen. Virol. 70, 1161–1172.
be excluded. Mumford, J. A., Hannant, D. A., Jessett, D. M., O’Neill, T., Smith, K. C.,
and Ostlund, E. N. (1995). Abortigenic and neurological disease
caused by experimental infection with equid herpesvirus-1. ‘‘Proc.ACKNOWLEDGMENTS
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